Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab in plaque-type psoriasis (EXPRESS II)
NCT00106847Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jan 2003
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of infliximab in plaque psoriasis, sponsored by Janssen Pharmaceutical. Started Jan 2003; status: completed.
02
Drugs
infliximab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00106847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00106847.